Uni-Bio Science Group Limited — Capital/Financing Update 2014

Sep 12, 2014

Hong Kong Exchanges and Clearing Limited and The Stock Exchange of Hong Kong Limited take no responsibility for the contents of this announcement, make no representation as to its accuracy or completeness and expressly disclaim any liability whatsoever for any loss howsoever arising from or in reliance upon the whole or any part of the contents of this announcement.

==> picture [28 x 33] intentionally omitted <==

==> picture [22 x 25] intentionally omitted <==

==> picture [24 x 28] intentionally omitted <==

==> picture [291 x 46] intentionally omitted <==

(Incorporated in the Cayman Islands with limited liability)

(Stock code: 0690)

GRANT OF SHARE OPTIONS

This announcement is made pursuant to Rule 17.06A of the Rules Governing the Listing of Securities on The Stock Exchange of Hong Kong Limited (the “ Listing Rules ”).

The board of directors of Uni-Bio Science Group Limited (the “ Company ”) hereby announces that on 12 September 2014, share options (the “ Options ”) in respect of 8,920,000 ordinary shares of the Company (the “ Shares ”) were granted to eligible grantees under the share option scheme adopted by the Company on 22 September 2006 (the 10% general limit under the said share option scheme was refreshed pursuant to a resolution passed at the annual general meeting of the Company held on 29 August 2014). The followings are the details of the Options granted:

Date of grant

Number of Options granted

: 12 September 2014 : 8,920,000

Exercise price of Options granted

: HK$0.230 per Share

Closing price of the Shares on the : HK$0.221 per Share date of grant

The average closing price of the : HK$0.230 per Share Shares for the five business days immediately preceding the date of grant

Validity period of the Options

• : From 12 September 2014 to 11 September 2024

• For identification purpose only

– 1 –

Vesting	period	of	the	Options	:	(i)	2,500,000 Options are vested	2,500,000 Options are vested	2,500,000 Options are vested	immediately	immediately
							on 12 September 2014;
						(ii)	40,000 Options	will	be	vested	on
							12 October 2014;
						(iii)	40,000 Options	will	be	vested	on
							12 November 2014;
						(iv)	40,000 Options	will	be	vested	on
							12 December 2014;
						(v)	40,000 Options	will	be	vested	on
							12 January 2015;
						(vi)	40,000 Options	will	be	vested	on
							12 February 2015;
						(vii)	40,000 Options	will	be	vested	on
							12 March 2015;
						(viii)	40,000 Options	will	be	vested	on
							12 April 2015;
						(ix)	40,000 Options	will	be	vested	on
							12 May 2015;
						(x)	40,000 Options	will	be	vested	on
							12 June 2015;
						(xi)	3,030,000 Options will		be	vested	on
							12 September 2015;
						(xii)	3,030,000 Options will		be	vested	on
							12 September 2016.

– 2 –

Among the Share Options granted above, a total of 8,560,000 were granted to the Directors of the Company, details of which are as follows:

		Number of the
		Share Options
Name of Grantees	Relationship with the Company	granted
Mr. TONG Kit Shing	Executive Director	780,000
Mr. Kingsley LEUNG	Executive Director	2,940,000
Mr. FUNG Kwok Leung	Non-executive Director	780,000
Mr. TSAO Hoi Ho, Terry	Independent non-executive Director	940,000
Dr. Carl Aslan Jason Morton FIRTH	Independent non-executive Director	1,560,000
Mr. ZHAO Zhi Gang	Independent non-executive Director	1,560,000

The grant of the Share Options to the above Directors has been approved by the Board in accordance with rule 17.04(1) of the Listing Rules.

Save as disclosed above, none of the Grantee is a Director, chief executive or Substantial Shareholder, or their respective associates (as defined in the Listing Rules).

By Order of the Board of Uni-Bio Science Group Limited Tong Kit Shing Chairman

Hong Kong, 12 September 2014

As at the date of this announcement, the Board comprises two executive Directors, namely, Mr. TONG Kit Shing (Chairman) and Mr. Kingsley LEUNG; one non-executive Director, namely, Mr. FUNG Kwok Leung; and three independent non-executive Directors, namely, Mr. TSAO Hoi Ho, Terry, Dr. Carl Aslan Jason Morton FIRTH and Mr. ZHAO Zhi Gang.

– 3 –